These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
485 related items for PubMed ID: 1380897
1. Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation. Zarcone D, Viale O, Cerruti G, Tenca C, Malorni W, Arancia G, Iosi F, Galandrini R, Velardi A, Moretta A. Cell Immunol; 1992 Sep; 143(2):389-404. PubMed ID: 1380897 [Abstract] [Full Text] [Related]
2. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity. Galandrini R, Albi N, Zarcone D, Grossi CE, Velardi A. Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184 [Abstract] [Full Text] [Related]
3. Target lysis by human LAK cells is critically dependent upon target binding properties, but LFA-1, LFA-3 and ICAM-1 are not the major adhesion ligands on targets. Quillet-Mary A, Cavarec L, Kermarrec N, Marchiol-Fournigault C, Gil ML, Conjeaud H, Fradelizi D. Int J Cancer; 1991 Feb 01; 47(3):473-9. PubMed ID: 1704356 [Abstract] [Full Text] [Related]
4. Participation of CD11a-c/CD18, CD2 and RGD-binding receptors in endogenous and interleukin-2-stimulated NK activity of CD3-negative large granular lymphocytes. Timonen T, Gahmberg CG, Patarroyo M. Int J Cancer; 1990 Dec 15; 46(6):1035-40. PubMed ID: 1979068 [Abstract] [Full Text] [Related]
5. Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells. Oblakowski P, Bello-Fernandez C, Reittie JE, Heslop HE, Galatowicz G, Veys P, Wilkes S, Prentice HG, Hazlehurst G, Hoffbrand AV. Blood; 1991 May 01; 77(9):1996-2001. PubMed ID: 1708296 [Abstract] [Full Text] [Related]
6. Enhancement of MHC-unrestricted cytotoxic activity of human CD56+ CD3- natural killer (NK) cells and CD3+ T cells by rhamnogalacturonan: target cell specificity and activity against NK-insensitive targets. Zhu HG, Zollner TM, Klein-Franke A, Anderer FA. J Cancer Res Clin Oncol; 1994 May 01; 120(7):383-8. PubMed ID: 7514604 [Abstract] [Full Text] [Related]
7. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis. Robertson MJ, Caligiuri MA, Manley TJ, Levine H, Ritz J. J Immunol; 1990 Nov 15; 145(10):3194-201. PubMed ID: 1700001 [Abstract] [Full Text] [Related]
8. Interleukin-2-activated murine cell lines with macrophage- and B-lymphoblast-lytic activity. Suzuki H, Ikemoto M, Yokoyama A, Kamitani T, Yamashita N, Maruyama M, Yano S. Cell Immunol; 1991 Jan 15; 132(1):127-39. PubMed ID: 1829651 [Abstract] [Full Text] [Related]
9. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier LL. J Immunol; 1992 Aug 15; 149(4):1115-23. PubMed ID: 1380031 [Abstract] [Full Text] [Related]
10. Stimulation of IFN-gamma, TNF-alpha, and TNF-beta secretion in IL-2-activated T cells: costimulatory roles for LFA-1, LFA-2, CD44, and CD45 molecules. Chong AS, Boussy IA, Graf LH, Scuderi P. Cell Immunol; 1992 Oct 01; 144(1):69-79. PubMed ID: 1356634 [Abstract] [Full Text] [Related]
16. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. Moretta A, Bottino C, Pende D, Tripodi G, Tambussi G, Viale O, Orengo A, Barbaresi M, Merli A, Ciccone E. J Exp Med; 1990 Dec 01; 172(6):1589-98. PubMed ID: 2147946 [Abstract] [Full Text] [Related]
17. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor. Bolhuis RL, Roozemond RC, van de Griend RJ. J Immunol; 1986 Jun 01; 136(11):3939-44. PubMed ID: 3084649 [Abstract] [Full Text] [Related]
20. Cultured human thymocytes lacking CD2 and CD11a/CD18 antigens are functional and adhere to endothelial cells via CD56 or CDw49d molecules. Poggi A, Zocchi MR. Cell Immunol; 1992 Apr 01; 140(2):319-30. PubMed ID: 1371947 [Abstract] [Full Text] [Related] Page: [Next] [New Search]